成功治疗的HIV阳性患者CD4/CD8比值低时炎性小体组分表达变化
该研究纳入18例CD4/CD8比值低的成功治疗HIV阳性患者、17例比值正常患者和11名健康供者,发现低比值患者经典和中间单核细胞CCR2表达降低、经典单核细胞CCR5表达升高,且脂多糖刺激后NAIP和PYCARD mRNA水平更高,提示免疫激活控制能力改变可能影响免疫重建。
要点
- 成功治疗HIV患者CD4/CD8比值低时单核细胞CCR2降低、CCR5升高
- 低比值患者脂多糖刺激后NAIP和PYCARD mRNA水平更高
- 炎性小体组分表达改变可能影响免疫重建
核心结论
- 成功治疗的HIV阳性患者CD4/CD8比值低与单核细胞趋化因子受体表达改变及脂多糖刺激后NAIP、PYCARD mRNA水平升高相关。
研究设计与样本
- 研究纳入18例CD4/CD8比值低的成功治疗HIV阳性患者、17例比值正常患者和11名健康供者,检测单核细胞炎性小体组分表达。
主要发现
- 与比值正常患者相比,低比值患者经典和中间单核细胞CCR2表达降低。
- 与比值正常患者相比,低比值患者经典单核细胞CCR5表达升高。
- 低比值患者脂多糖刺激后NAIP和PYCARD信使RNA水平更高。
临床怎么用
- 对于成功治疗但CD4/CD8比值低的HIV患者,可关注单核细胞炎性小体相关标志物以评估免疫激活控制状态。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The expression and activity of main inflammasome components in monocytes from successfully treated human immunodeficiency virus (HIV)-positive patients are poorly studied. Thus, we enrolled 18 patients with a low and 17 with a normal ratio of CD4+ T cells to CD8+ T cells and 11 healthy donors. We found that patients with a low ratio had decreased CCR2 expression among classical and intermediate monocytes and increased CCR5 expression among classical monocytes, compared with patients with a normal ratio. Patients with a low ratio also had higher NAIP and PYCARD messenger RNA levels after lipopolysaccharide stimulation, suggesting an altered ability to control immune activation that could affect their immune reconstitution.
引用
- Nasi M, Pecorini S, De Biasi S, et al. Altered Expression of PYCARD, Interleukin 1β, Interleukin 18, and NAIP in Successfully Treated HIV-Positive Patients With a Low Ratio of CD4+ to CD8+ T Cells. J Infect Dis. 2019. PMID: 30590710. doi:10.1093/infdis/jiy730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。